Journal of Applied Physiology, Vol 80, Issue 5 1674-1680, Copyright © 1996 by American Physiological Society

ARTICLES

Postnatal lung responses and surfactant function after fetal or maternal corticosteroid treatment

C. M. Rebello, M. Ikegami, D. H. Polk and A. H. Jobe
Department of Pediatrics, Harbor-UCLA Medical Center, University of California, Los Angeles School of Medicine, Torrance 90509, USA.

To evaluate the effect of dose and route of administration of betamethasone on subsequent postnatal lung function, pregnant ewes were randomized at 127 days gestation to receive maternal or fetal intramuscular doses of 0.2 or 0.5 mg/kg body wt betamethasone or saline. At delivery 24 h later, preterm lambs were treated with surfactant and ventilated for 4 h. The lambs exposed to 0.5 mg/kg betamethasone by either the maternal or fetal route had higher Po2 values, lung volumes, dynamic compliances, and ventilatory efficiency indexes, as well as lower ventilatory pressure requirements, than did control animals (P < 0.05). There were no consistent improvements in postnatal lung function for the 0.2 mg/kg dose given to the fetus or ewe. However, measurements of radiolabeled protein in the total lung were decreased in all treatment groups (P < 0.01). Surfactant that was recovered from all groups of lambs and fractionated to isolate the large-aggregate fraction improved lung volumes in preterm rabbits to a greater degree than the surfactant used to treat the lambs (P < 0.05). Surfactant recovered from both groups treated with 0.5 mg/kg betamethasone was less sensitive to inactivation by plasma than was surfactant from the 0.2 mg/kg groups or the controls (P < 0.01). Fetal or maternal treatment with 0.5 mg/kg betamethasone improved postnatal lung function and increased the resistance of surfactant to inactivation.

This article has been cited by other articles:

				J. J Henderson, P. E Hartmann, T. J M Moss, D. A Doherty, and J. P Newnham Disrupted secretory activation of the mammary gland after antenatal glucocorticoid treatment in sheep Reproduction, November 1, 2008; 136(5): 649 - 655. [Abstract] [Full Text] [PDF]

				T. J. M. Moss, I. Nitsos, R. Harding, and J. P. Newnham Differential Effects of Maternal and Fetal Betamethasone Injections in Late-Gestation Fetal Sheep Reproductive Sciences, December 1, 2003; 10(8): 474 - 479. [Abstract] [PDF]

				J. Molnar, M. J. M. Nijland, D. C. Howe, and P. W. Nathanielsz Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R561 - R567. [Abstract] [Full Text] [PDF]

				R. C. Tan, M. Ikegami, A. H. Jobe, L. Y. Yao, F. Possmayer, and P. L. Ballard Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1142 - L1148. [Abstract] [Full Text] [PDF]

				A. H. Jobe, J. Newnham, K. Willet, P. Sly, and M. Ikegami Fetal Versus Maternal and Gestational Age Effects of Repetitive Antenatal Glucocorticoids Pediatrics, November 1, 1998; 102(5): 1116 - 1125. [Abstract] [Full Text]

				N. Wada, M. G. Ervin, and M. Ikegami Effect of ventilation style on cardiovascular and renal adaptation in preterm newborn lambs Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R836 - R843. [Abstract] [Full Text] [PDF]

				C. M. Rebello, M. Ikegami, M. G. Ervin, D. H. Polk, and A. H. Jobe Postnatal lung function and protein permeability after fetal or maternal corticosteroids in preterm lambs J Appl Physiol, July 1, 1997; 83(1): 213 - 218. [Abstract] [Full Text] [PDF]

				M. IKEGAMI, A. H. JOBE, J. NEWNHAM, D. H. POLK, K. E. WILLET, and P. SLY Repetitive Prenatal Glucocorticoids Improve Lung Function and Decrease Growth in Preterm Lambs Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 178 - 184. [Abstract] [Full Text]